Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2013 Sep 3;139(10):10.1007/s00432-013-1501-6. doi: 10.1007/s00432-013-1501-6

Figure 5. Dot blot analysis with pooled cancer and benign samples.

Figure 5

Dot blot analysis was performed using recombinant autoantigens and pooled serum samples from benign ovarian disease, stage I, stage II-IV, and stage I-IV ovarian cancer (Table 1B). An example (PDZ) of the dot blot image is given on the right.